Withana et al. showed that an altered version of this probe, BMV109, targeting both cathepsin B, L, and S, had enhanced imaging properites in vivo. In addition, it enabled rapid imaging of enzyme activity in fresh frozen human breast cancer tissue sections [130, 131]. Here, CTSB is linked to breast carcinoma.